Literature DB >> 12463440

Ankylosing spondylitis--cardiac manifestations.

D Lautermann1, J Braun.   

Abstract

There is a definite association of heart disease with ankylosing spondylitis (AS). The magnitude of this relationship is less clear. Three types of inflammatory affections can be differentiated: 1. aortitis and aortic insufficiency with the possible necessity of cardiac surgery, 2. conduction disturbances of the atrioventricular node with a probable subsequent indication for a pacemaker and 3. myocardial involvement with a possible compromise of left ventricular function. There seems to be an HLA B27-associated cardiac syndrome consisting of aortic root disease and conduction abnormalities. Patients can be recognized at pre-clinical stages. Prospective studies have not been performed. HLA B27-related heart disease does not seem to be associated with increased mortality.

Entities:  

Mesh:

Year:  2002        PMID: 12463440

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  41 in total

Review 1.  Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.

Authors:  Jürgen Braun; Klaus Krüger; Bernhard Manger; Matthias Schneider; Christof Specker; Hans Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2017-03-24       Impact factor: 5.594

Review 2.  [Acute rheumatic fever (ARF) and poststreptococcal reactive arthritis (PSRA)--an update].

Authors:  R Keitzer
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

Review 3.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

4.  NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study.

Authors:  Julio C B Moraes; Ana C M Ribeiro; Carla G S Saad; Alessandro C Lianza; Clovis A Silva; Eloísa Bonfá
Journal:  Clin Rheumatol       Date:  2013-02-05       Impact factor: 2.980

5.  The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009.

Authors:  John D Reveille; Rosemarie Hirsch; Charles F Dillon; Margaret D Carroll; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2012-05

6.  Left ventricular systolic dysfunction in patients with ankylosing spondylitis without clinically overt cardiovascular disease by speckle tracking echocardiography.

Authors:  Nilgun Ustun; Mustafa Kurt; Alper Bugra Nacar; Hacer Paksoy Karateke; Hayal Guler; Ayse Dicle Turhanoglu
Journal:  Rheumatol Int       Date:  2014-09-19       Impact factor: 2.631

7.  Etanercept treatment-related c-ANCA-associated large vessel vasculitis.

Authors:  Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Nina Boulman; Michael Rozenbaum; Lisa Kaly; Ofrat Katz Beyar; Doron Rimar
Journal:  Clin Rheumatol       Date:  2015-12-01       Impact factor: 2.980

8.  Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.

Authors:  Ashit Syngle; Kanchan Vohra; Anjali Sharma; L Kaur
Journal:  Clin Rheumatol       Date:  2010-03-05       Impact factor: 2.980

9.  Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?

Authors:  Florian Brunner; Andres Kunz; Ulrich Weber; Rudolf Kissling
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

Review 10.  [Epidemiology and prognostic aspects of ankylosing spondylitis].

Authors:  J Braun
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.